EAU 2013 - Programme Book - YouMed

Monday, 18 March - EAU Programme
Abstract Session
15.45 - 17.15 Prostate cancer treatment: Comorbidities and complications
Brown Hall 1-2 - Level S2
Poster Session 83
Chairs: M. Graefen, Hamburg (DE)
R.E. Sanchez Salas, Paris (FR)
Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes
in length, followed by 2 minutes for discussion.
1011 Health-related quality of life after radical prostatectomy is independent of patient’s age and comorbidities
K. Herkommer, H. Schulwitz, T. Klorek, S. Schmid, C. Hofer, J.E. Gschwend, M. Kron (Munich, Ulm, Germany)
1012 Analysis on overall, cancer-specific and non-cancer-specific survivals according to Charlson comorbidity
index in prostate cancer patients who underwent radical prostatectomy
J.Y. Lee, K.H. Kim, J.W. Park, R.R. Diaz, K.H. Kim, H.Y. Lee, W.S. Ham, N.H. Cho, Y.D. Choi, K.S. Cho (Seoul,
South Korea)
1013 Perioperative and early oncological outcomes after robotic assisted radical prostatectomy in morbidly
obese patients: A propensity matched study
H. Abdul-Muhsin, C. Giedelman, S. Samavedi, O. Schatloff, S. Chauhan, A. Sivaraman, R. Coelho, K. Palmer,
G. Ebra, V. Patel (Celebration, United States of America)
1014 The impact of abdominal obesity on surgical complications and functional outcomes in men treated with
radical prostatectomy for prostate cancer: Results of an Italian multicentre survey (M.I.R.R.O.R.)
M. Gacci, A. Sebastianelli, M. Salvi, C. De Nunzio, R. Schiavina, A. Simonato, A. Tubaro, V. Mirone, M. Carini,
G. Carmignani (Florence, Rome, Bologna, Genova, Naples, Italy)
1015 Cardiovascular disease and prostate cancer: A competing-risks analysis
J. Hansen, F.K. Chun, M. Rink, S.F. Shariat, M. Graefen, M. Sun (Hamburg, Germany; New York City, United
States of America; Montreal, Canada)
1016 Is extended venous thrombo-embolism pharmacological prophylaxis required following laparoscopic
radical prostatectomy?
B. Horsburgh, V. Srinivasan (Denbighshire, United Kingdom)
1017 Prospective randomized study comparing transperitoneal and extraperitoneal approach during robotic
prostatectomy: Anesthesiologic effects
F. Dal Moro, C. Valotto, A. Mangano, R. Soncin, A. Crestani, A. Guttilla, G.M. Pittoni, F. Zattoni (Padua, Italy)
1018 Difficult radical prostatectomy did not cause inferior functional outcome
U.H.G. Michl, M. Graefen, A. Haese, G. Salomon, H. Heinzer, T. Schlomm, T. Steuber, H. Huland (Hamburg,
Germany)
1019 Invasiveness and post aggression metabolism in DaVinci prostatectomies - the iPOD study
A. Martinschek, L. Stumm, M. Ritter, E. Heinrich, L. Trojan (Ulm, Mannheim, Göttingen, Germany)
1020 Characterization, incidence and severity of surgical complications using Clavien system in patients treated
with minimally invasive radical prostatectomy
A.M. Autran, R.E. Sanchez Salas, E. Barret, F. Rozet, D. Prapotnich, M. Galiano, N. Cathala, A. Mombet,
F. Secin, X. Cathelineau (Paris, France; Buenos Aires, Argentina)
EAU Milan 2013
301
Monday